Mina Baskharoun
Neurology · New Orleans, LANPI 1528645546
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations.
Across 87 payments — averaging $38.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$759
- Argenx US, Inc.$481
- Amgen$335
- Eisai Inc.$292
- EMD Serono, Inc.$223
- Neurelis, Inc.$164
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,322100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 16 | $759 |
| Argenx US, Inc. | 9 | $481 |
| Amgen | 10 | $335 |
| Eisai Inc. | 14 | $292 |
| EMD Serono, Inc. | 3 | $223 |
| Neurelis, Inc. | 8 | $164 |
| AbbVie | 3 | $148 |
| Sanofi | 1 | $126 |
| Jazz Pharmaceuticals Inc. | 1 | $122 |
| Acadia Pharmaceuticals Inc | 1 | $122 |
| CSL Behring | 4 | $88 |
| Neurocrine Biosciences, Inc. | 3 | $86 |
| AstraZeneca | 1 | $73 |
| Octapharma USA, Inc. | 2 | $70 |
| Biogen | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| SK Life Science, Inc. | 2 | $39 |
| Merz Pharmaceuticals, LLC | 1 | $25 |
| Johnson & Johnson | 1 | $20 |
| Tanabe Pharma America, Inc. | 1 | $20 |
| Aucta Pharmaceuticals, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,322 in reported general payments places this provider in the 55th percentile of 225 neurology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MayzentSiponimod | 13 | $125,477 |
| Levetiracetam | 33 | $466 |
| Carbamazepine | 11 | $243 |
| Gabapentin | 11 | $209 |
| Lamotrigine | 12 | $207 |
| Amitriptyline Hcl | 16 | $63 |
| Topiramate | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Other neurology in New Orleans
- John EnglandNew Orleans$268K
- Brian CopelandNew Orleans$211K
- Bridget BagertNew Orleans$198K
- Sheryl Martin-SchildNew Orleans$106K
- Piotr OlejniczakNew Orleans$82K
- Elizabeth CrabtreeNew Orleans$36K
- Caroline GoldinNew Orleans$36K
- Jesus LoveraNew Orleans$27K
- Julia StaischNew Orleans$22K
- Pooja Mohan RaoNew Orleans$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.